CD8A and neoplasm: To further investigate the effect of NACT ± P on T cells, we stained paired tumor samples from the 64 patients with a 7-color immunofluorescence panel (CD4, CD8, PD-1, Ki67, ActCasp3, panCK) to analyze changes in tumor cells and T cell subsets upon treatment (Supplementary Fig. 3A).